France· FR:65915266
CYAMEMAZINE VIATRIS 25 mg, comprimé pelliculé sécable
A cyamemazine product containing tartrate de cyamémazine, registered in France by VIATRIS SANTE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TARTRATE DE CYAMÉMAZINE
- Manufacturer
- VIATRIS SANTE
- Country
- France (FR)
- ATC code
- N05AA06
- ATC class
- Cyamemazine
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 3
1 priced- cip133400930097533plaquette(s) PVC aluminium de 30 comprimé(s)EUR 3.61
- cip133400955068143100 plaquette(s) unitaires prédécoupées PVC aluminium de 1 comprimé(s)
- cip133400955091400flacon(s) polyéthylène haute densité (PEHD) de 100 comprimé(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under N05AA06
Cyamemazine, as other registers publish it.
- FranceCYAMEMAZINE ARROW 100 mg, comprimé pelliculé sécableARROW GENERIQUES
- FranceCYAMEMAZINE ARROW 25 mg, comprimé pelliculé sécableARROW GENERIQUES
- FranceCYAMEMAZINE BIOGARAN 100 mg, comprimé pelliculé sécableBIOGARAN
- FranceCYAMEMAZINE BIOGARAN 25 mg, comprimé pelliculé sécableBIOGARAN
- FranceCYAMEMAZINE VIATRIS 100 mg, comprimé pelliculé sécableVIATRIS SANTE
- FranceTERCIAN 100 mg, comprimé pelliculé sécableATNAHS PHARMA FRANCE
- FranceTERCIAN 40 mg/ml, solution buvable en gouttesATNAHS PHARMA FRANCE
- FranceTERCIAN 50 mg/5 ml, solution injectable en ampouleATNAHS PHARMA FRANCE
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Portugal · Ciamemazina Generis, Tercian
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2a98cb8a-b502-4b6d-9837-81748ca7c362 GET /v1/drugs/2a98cb8a-b502-4b6d-9837-81748ca7c362?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65915266",
"date_amm": "2017-06-13",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "TARTRATE DE CYAMÉMAZINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé sécable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about cyamemazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.